Effect of Breathing Exercise During Peripheral Intravenous Catheter

Venipuncture Clinical Trial

Official title:

Effect of Breathing Exercise During Peripheral Intravenous Catheter Implementation on Pain, Anxiety, and Patient Satisfaction

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05680649
• Other study ID #: 573/2022
• Status: Completed
• Phase: N/A
• Start date: February 24, 2022
• Est. completion date: July 28, 2022

Study information

• Verified date: December 2022
• Source: TC Erciyes University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study was carried out to determine the effect of breathing exercise performed during peripheral intravenous catheter (PIVC) application on pain, anxiety and patient satisfaction. The study was completed as a randomized controlled experimental study with a total of 130 individuals who met the inclusion criteria. The Descriptive Characteristics Questionnaire, the State-Trait Anxiety Inventory, and the Numerical Rating Scale were used to collect the data of the study. In addition, Algometer (66 Lb/30 Kg) device was used to evaluate the pain pressure threshold in determining the individuals to be included in the research sample. The individuals in the intervention group were given diaphragmatic breathing exercise while applying the catheter, and the individuals in the control group were inserted without any application.

Description:

This study was carried out to determine the effect of breathing exercise performed during peripheral intravenous catheter (PIVC) application on pain, anxiety and patient satisfaction. The study was completed as a randomized controlled experimental study with a total of 130 individuals who met the inclusion criteria, 65 of whom were in the intervention group and 65 in the control group. Ethics committee approval, institutional permission, and written informed consent from individuals were obtained in the study. The Descriptive Characteristics Questionnaire, the State-Trait Anxiety Inventory, and the Numerical Rating Scale were used to collect the data of the study. In addition, Algometer (66 Lb/30 Kg) device was used to evaluate the pain pressure threshold in determining the individuals to be included in the research sample. The individuals in the intervention group were given diaphragmatic breathing exercise while applying the catheter, and the individuals in the control group were inserted without any application.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 130
• Est. completion date: July 28, 2022
• Est. primary completion date: July 28, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• able to speak and understand Turkish,
• between the ages of 18-65,
• having orientation to place and time,
• without any psychiatric disease and hearing problems,
• not using central nervous system drugs,
• people who having PIVC indication,
• no analgesic or anesthetic agent was applied 24 hours before PIVC application,
• not have any pain in any part of the body that may affect the results of the study,
• no PIVC experience in the last month,
• 20-G catheter will be applied,
• pressure pain threshold mean of 8-16 pounds (Lb), (11) individuals who volunteered to participate in the study.

Exclusion Criteria:

• Infection in the area where PIVC will be applied, -having previous operation, scarring, psoriasis, active dermatitis in the area - -
• where PIVC will be applied,
• with peripheral nerve disease,
• no catheter applied to the forearm veins,
• having diabetes,
• with peripheral neuropathy,
• diagnosed with cancer,
• receiving cancer treatment,
• with respiratory disease,
• who have an obstacle to breathing exercise,
• in the post-surgical period,
• individuals who did not volunteer to participate in the study

Related Conditions & MeSH terms

• Respiratory Aspiration
• Venipuncture

Intervention

Other:
• Breathing exercise
Diaphragmatic breathing exercises were taught to the individuals by the researcher and they were asked to start breathing exercises before starting PIVC. While the PIVC was being placed, the individuals continued the breathing exercise and the breathing exercise was terminated at the end of the application.

Locations

Country	Name	City	State
Turkey	Erciyes University	Kayseri

Sponsors (1)

Lead Sponsor	Collaborator
TC Erciyes University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain level	Pain level measured with Numeric Rating Scale. The number "0" on the scale means that they do not feel any pain and the number "10" refers to the worst pain.	3 minutes after catheter insertion
Primary	Anxiety level	Anxiety level measured with Numeric Rating Scale. The number "0" on the scale means that they do not feel any anxiety and the number "10" refers to the highest level of anxiety.	3 minutes after catheter insertion
Secondary	Satisfaction level	Satisfaction level measured with Numeric Rating Scale. The number "0" in the scale indicates that the participants are not at all satisfied with the application, and the number "10" indicates the highest level of satisfaction.	3 minutes after catheter insertion